Overview

TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma.
Phase:
Phase 3
Details
Lead Sponsor:
Children's Oncology Group
Collaborators:
Children's Cancer and Leukaemia Group
National Cancer Institute (NCI)
Societe Francaise Oncologie Pediatrique
Treatments:
Cortisol succinate
Cyclophosphamide
Cytarabine
Doxorubicin
Etoposide
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Liposomal doxorubicin
Methotrexate
Prednisolone
Prednisone
Vincristine